Skip to content

Resolute Science

5 viewers · 30d

Total raised

$2.9M

2 filings since 2025 · latest SAFE filed

Cumulative raised
LAST ROUND
SAFE · $2.9M
ROUNDS
2
INVESTORS
9
FOUNDED
2020
HQ
San Diego, CA
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
5

AI overview

Updated

Resolute Science, Inc. is a biotechnology company dedicated to advancing cancer treatment through innovative therapeutic strategies. The company specializes in addressing the challenges of solid tumor cancers, with a focus on overcoming recurrence and drug resistance.

What sets it apart

Resolute Science stands out with their MAC-TAC platform, which leverages Tumor-Associated Macrophages to deliver cytotoxic payloads, a method distinct from conventional cancer cell targeting.

Funding history

2 rounds
SAFE+1Feb 3, 2025
Form D
+$1.4M$2.9M total
SAFE+1Feb 3, 2025
Form D/A
+$2.9M$2.9M total

Products

1 tracked

MAC-TAC Platform

Cancer Therapeutics

The MAC-TAC platform is a groundbreaking technology in cancer therapeutics, specifically designed to harness Tumor-Associated Macrophages. These macrophages are used to transport cytotoxic agents directly to tumors, providing a targeted, robust attack on cancer cells.

  • Leverages Tumor-Associated Macrophages
  • Delivers cytotoxic payloads directly to tumors
  • Offers an alternative to traditional cancer cell targeting

Links

WebsiteSEC EDGAR filings